IL1A and gout: The classic autoinflammatory diseases are rare, including neonatal-onset multisystem inflammatory disease, Muckle-Wells syndrome, familial cold-induced autoinflammatory syndrome, hyperimmunoglobulin D syndrome, etc. Recently, the benefit of IL-1 blockage has expanded to rare conditions, such as gout, diabetes mellitus and even myeloma.